Company · CIK 0001708493 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Harpoon Therapeutics, Inc. · HARP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2019 PForm 4 → | Feb 14, 6:01 pm EST | Arix Bioscience plc +110% Owner | 428,571 | $14.00 | $5,999,994 | 2,892,119 | +17.4% | plan? |
| Feb 12, 2019 CForm 4 → | Feb 14, 6:01 pm EST | Arix Bioscience plc +110% Owner | 2,463,548 | — | — | 2,463,548 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:34 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 250,000 | $14.00 | $3,500,000 | 3,898,422 | +6.85% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 5:34 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 447 | $14.00 | $6,258 | 3,648,422 | −0.01% | plan? |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:34 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 3,648,869 | $0.0492 | $6,253 | 3,648,869 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:33 pm EST | New Leaf Ventures III, L.P. +510% Owner | 428,571 | $14.00 | $5,999,994 | 678,566 | +171% | plan? |
| Feb 12, 2019 CForm 4 → | Feb 14, 5:33 pm EST | New Leaf Ventures III, L.P. +510% Owner | 2,492,834 | — | — | 464,281 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:32 pm EST | MPM BioVentures 2014, L.P. +610% Owner | 250,000 | $14.00 | $3,500,000 | 4,524,425 | +5.85% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 5:32 pm EST | MPM BioVentures 2014, L.P. +610% Owner | 1,524 | $14.00 | $21,336 | 4,274,425 | −0.04% | plan? |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:32 pm EST | MPM BioVentures 2014, L.P. +610% Owner | 3,953,886 | $0.0492 | $21,260 | 4,275,949 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:30 pm EST | Ronald HuntDirector, 10% Owner | 428,571 | $14.00 | $5,999,994 | 678,566 | +171% | plan? |
| Feb 12, 2019 CForm 4 → | Feb 14, 5:30 pm EST | Ronald HuntDirector, 10% Owner | 2,492,834 | — | — | 464,281 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:28 pm EST | Ansbert Gadicke10% Owner | 500,000 | $14.00 | $7,000,000 | 8,422,847 | +6.31% | plan? |
| Feb 12, 2019 SForm 4 → | Feb 14, 5:28 pm EST | Ansbert Gadicke10% Owner | 1,971 | $14.00 | $27,594 | 7,922,847 | −0.02% | plan? |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:28 pm EST | Ansbert Gadicke10% Owner | 7,602,755 | $0.0492 | $27,513 | 7,924,818 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:24 pm EST | Mark ChinDirector, 10% Owner | 428,571 | $14.00 | $5,999,994 | 2,892,119 | +17.4% | plan? |
| Feb 12, 2019 CForm 4 → | Feb 14, 5:24 pm EST | Mark ChinDirector, 10% Owner | 2,463,548 | — | — | 2,463,548 | — | plan? |
| Feb 12, 2019 PForm 4 → | Feb 14, 5:19 pm EST | Luke EvninDirector, 10% Owner | 250,000 | $14.00 | $3,500,000 | 4,524,425 | +5.85% | plan? |
| Feb 12, 2019 CFXForm 4 → | Feb 14, 5:19 pm EST | Luke EvninDirector, 10% Owner | 3,955,410 | $0.0982 | $42,596 | 4,274,425 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2019 CForm 4 → | Feb 14, 6:01 pm EST | Arix Bioscience plc +110% Owner | 2,463,548 | — | — | 0 | — | |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:34 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 3,648,869 | — | — | 0 | — | |
| Feb 12, 2019 CForm 4 → | Feb 14, 5:33 pm EST | New Leaf Ventures III, L.P. +510% Owner | 2,492,834 | — | — | 0 | — | |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:32 pm EST | MPM BioVentures 2014, L.P. +610% Owner | 3,953,886 | — | — | 0 | — | |
| Feb 12, 2019 CXForm 4 → | Feb 14, 5:28 pm EST | Ansbert Gadicke10% Owner | 7,602,755 | — | — | 0 | — | |
| Nov 9, 2018 ACPForm 4 → | Feb 14, 2019, 5:30 pm EST | Ronald HuntDirector, 10% Owner | 3,441,731 | — | — | 0 | — | late |
| Nov 9, 2018 ACPForm 4 → | Feb 14, 2019, 5:24 pm EST | Mark ChinDirector, 10% Owner | 3,226,733 | — | — | 0 | — | late |
| Nov 9, 2018 ACPXForm 4 → | Feb 14, 2019, 5:19 pm EST | Luke EvninDirector, 10% Owner | 4,392,073 | — | — | 0 | — | late |